close
MENU
General Business
3 mins to read

WheyTech Bionics in MPI partnership for diabetes remedy

A two-year project begins to develop technology to turn cheesemaking by-product into an alternative sugar.

MPI investment advisor Adam Walker with WheyTech Bionics chief executive Ben Van Rooy.

Kate McVicar Tue, 06 Sep 2022

WheyTech Bionics, a Wellington-based company researching uses for the cheesemaking by-product whey, has partnered with MPI on a two-year project to develop technology that could develop whey permeate into a product with anti-diabetic properties. 

WheyTech chief executive Ben Van Rooy spoke to NBR

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Kate McVicar Tue, 06 Sep 2022
Contact the Writer: kate@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
WheyTech Bionics in MPI partnership for diabetes remedy
General Business,
95652
true